Your browser doesn't support javascript.
loading
Cinnamic acid hybrids as anticancer agents: A mini-review.
Feng, Lian-Shun; Cheng, Jin-Bo; Su, Wen-Qi; Li, Hong-Ze; Xiao, Tao; Chen, De-An; Zhang, Zhi-Liu.
Afiliação
  • Feng LS; WuXi AppTec Co., Ltd., Wuhan, Peoples' Republic of China.
  • Cheng JB; WuXi AppTec Co., Ltd., Wuhan, Peoples' Republic of China.
  • Su WQ; WuXi AppTec Co., Ltd., Wuhan, Peoples' Republic of China.
  • Li HZ; WuXi AppTec Co., Ltd., Chengdu, Peoples' Republic of China.
  • Xiao T; WuXi AppTec Co., Ltd., Chengdu, Peoples' Republic of China.
  • Chen DA; WuXi AppTec Co., Ltd., Wuhan, Peoples' Republic of China.
  • Zhang ZL; WuXi AppTec Co., Ltd., Shanghai, Peoples' Republic of China.
Arch Pharm (Weinheim) ; 355(7): e2200052, 2022 Jul.
Article em En | MEDLINE | ID: mdl-35419808
Cancer, as a long-lasting and dramatic disease, affects almost one-third of human beings globally. Chemotherapeutics play an important role in cancer treatment, but multidrug resistance and severe adverse effects have already become the main causes of failure in tumor chemotherapy. Therefore, it is an urgent need to develop novel chemotherapeutics. Cinnamic acid contains a ubiquitous α,ß-unsaturated acid moiety presenting potential therapeutic effects in the treatment of cancer as these derivatives could act on cancer cells by diverse mechanisms of action. Accordingly, cinnamic acid derivatives are critical scaffolds in discovering novel anticancer agents. This review provides a comprehensive overview of cinnamic acid hybrids as anticancer agents. The structure-activity relationship, as well as the mechanisms of action, are also discussed, covering articles published from 2012 to 2021.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias / Antineoplásicos Limite: Humans Idioma: En Revista: Arch Pharm (Weinheim) Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias / Antineoplásicos Limite: Humans Idioma: En Revista: Arch Pharm (Weinheim) Ano de publicação: 2022 Tipo de documento: Article